Germline variants in acquired aplastic anemia: current knowledge and future perspectives

Area of Science:

• Hematology
• Genetics
• Immunology

Background:

• Aplastic anemia (AA) is a bone marrow failure disorder with inherited and acquired forms.
• Acquired AA is often considered immune-mediated, but genetic factors are increasingly recognized.
• Germline variants, previously linked to inherited bone marrow failure syndromes, are implicated in acquired AA.

Purpose of the Study:

• To explore the association between acquired AA and germline variants.
• To detail the clinical significance of germline variants in AA diagnosis and management.
• To encourage further research into the role of immunogenic variants and somatic mutations.

Main Methods:

• Review of existing literature on aplastic anemia and germline genetics.
• Analysis of evidence linking germline variants to AA pathogenesis.
• Discussion of diagnostic and management implications.

Main Results:

• Germline variants, often heterozygous, contribute significantly to acquired AA onset and progression.
• These variants are associated with mechanisms like gene homeostasis, DNA repair, and immune injury.
• Confirmed mutations in TERT and TERC are known contributors to inherited AA.

Conclusions:

• Germline variants are crucial in understanding acquired AA, beyond random immune-mediated processes.
• Clinical significance of germline variants aids in diagnosing and managing aplastic anemia.
• Further investigation is needed for immunogenic variants and potential secondary somatic mutations.